MLYS Earnings

Quarterly EPS
$-1.13
Q3 2024
$-0.98
Q4 2024
$-0.79
Q1 2025
$-0.66
Q2 2025
$-0.52
Q3 2025
$-0.40
Q4 2025
$-0.47
Q1 2026
$-2.85
Q2 2026
Latest RevenueN/A
Latest Net Income-241071000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$2.850-241071000—-331.8%
Q1 2026-$0.470-39339000—+40.5%
Q4 2025-$0.400-32234000—+59.2%
Q3 2025-$0.520-36932000—+54.0%
Q2 2025-$0.660-43274000—+20.5%
Q1 2025-$0.790-42211000—-12.9%
Q4 2024-$0.980-48946000—-60.7%
Q3 2024-$1.130-56342000—-98.2%
Q2 2024-$0.830-41014000——
Q1 2024-$0.700-31508000——
Q4 2023-$0.610-24389000——
Q3 2023-$0.570-22760000——
Mineralys Therapeutics (MLYS) — Earnings